Feb 22 |
3 Stocks to Turn $1,000 Into $1 Million: February 2024
|
Feb 15 |
Vivos Therapeutics announces exercise of warrants for proceeds of $4M
|
Feb 15 |
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds
|
Feb 12 |
Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions
|
Feb 6 |
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
|
Jan 8 |
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
|
Dec 11 |
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
|
Nov 30 |
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
|
Nov 30 |
Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea
|
Nov 29 |
Dow Jumps Over 100 Points; Hormel Foods Earnings Miss Estimates
|